In vitro activity of seven hospital biocides against Mycobacterium abscessus: Implications for patients with cystic fibrosis | Zendy

John E. Moore | Zendy; S. Caskey | Zendy; JacquelineC Rendall | Zendy

Open Access

In vitro activity of seven hospital biocides against Mycobacterium abscessus: Implications for patients with cystic fibrosis

Author(s) -

John E. Moore,

S. Caskey,

JacquelineC Rendall

Publication year - 2018

Publication title -

international journal of mycobacteriology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.53

H-Index - 20

eISSN - 2212-554X

pISSN - 2212-5531

DOI - 10.4103/ijmy.ijmy_197_17

Subject(s) - mycobacterium abscessus , cystic fibrosis , microbiology and biotechnology , biocide , in vitro , medicine , mycobacterium , chemistry , biology , pathology , biochemistry , tuberculosis

Mycobacterium abscessus pulmonary infection has recently emerged as a significant pathogen in patients with cystic fibrosis (CF) and is associated with significant morbidity and accelerated pulmonary decline. There is a paucity of data describing the activity of hospital biocides against this organism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research